News & Press Releases

Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp.

July 21st, 2014

Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp.   ASHKELON, Israel – July 21, 2014 — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, announced today that it has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into a Manufacturing Agreement […]

Read More

Integrity Applications, Inc. announces first wholesale orders for its GlucoTrack® model DF-F glucose measurement device and the hiring of a Director of Marketing and Sales

July 21st, 2014

Integrity Applications, Inc. announces first wholesale orders for its GlucoTrack® model DF-F glucose measurement device and the hiring of a Director of Marketing and Sales   ASHKELON, Israel, July 2, 2014 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack model DF-F noninvasive blood glucose measurement device, announced today […]

Read More

Integrity Applications Receives CE Mark Approval for Six-Month Calibration Validity of GlucoTrack® DF-F. Calibration Validity Now Corresponds to Lifespan of the Personal Ear Clip

March 22nd, 2014

Calibration Validity Now Corresponds to Lifespan of Personal Ear Clip ASHKELON, Israel, Mar 17, 2014 (BUSINESS WIRE) — Integrity Applications, Inc. (otcqb:IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, received CE Mark approval from Dekra Certification B.V., its Notified Body in the European Union, to extend its claim from a monthly recalibration […]

Read More

Integrity Applications Signs Two Additional Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device

March 22nd, 2014

Integrity Applications Signs Two Additional Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device GlucoTrack® Will Be Available in the Philippines and Chile  ASHKELON, Israel – March 20, 2014 — Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its wholly-owned subsidiary, Integrity Applications […]

Read More

Integrity Applications Receives CE Mark Approval for Six-Month Calibration Validity of GlucoTrack® DF-F

March 19th, 2014

Integrity Applications Receives CE Mark Approval for Six-Month Calibration Validity of GlucoTrack® DF-F   Calibration Validity Now Corresponds to Lifespan of Personal Ear Clip   ASHKELON, Israel – March 17, 2014 — Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, received CE Mark approval from Dekra Certification […]

Read More Download

Integrity Applications Signs Third Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device

January 29th, 2014

Integrity Applications Signs Third Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device Distributor Felkasta JSC Expected to Begin Sales by Q2 2014 in Lithuania, Latvia and Estonia and 2015 in Belarus ASHKELON, Israel Integrity Applications, Inc. (IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its subsidiary company, Integrity […]

Read More

Integrity Applications Signs Additional Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device

January 15th, 2014

Integrity Applications Signs Additional Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device Turkish Distributor Kocak Medical & Laboratory Technology Expected to Begin Sales by End of Second Quarter 2014 January 14, 2014 ASHKELON, ISRAEL — Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack®model DF-F non-invasive blood glucose measurement device, has entered into a distribution […]

Read More

Integrity Applications Signs Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device

January 15th, 2014

Integrity Applications Signs Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device Integrity Applications, Inc.January 13, 2014 7:00 AM ASHKELON, Israel–(BUSINESS WIRE)– Integrity Applications, Inc. (IGAP), developer of the GlucoTrack® model DF-F non-invasive blood glucose measurement device, has entered into a distribution agreement appointing Ultramedix Australasia Pty Ltd., with their depth of specialist clinical expertise and […]

Read More

Integrity Applications to Present at the Sidoti & Company Semi-Annual Micro-Cap Conference in New York City on January 13, 2014

January 8th, 2014

http://www.businesswire.com/news/home/20140108005181/en/Integrity-Applications-Present-Sidoti-Company-Semi-Annual-Micro-Cap#.Us1MOhYQSlI Integrity Applications to Present at the Sidoti & Company Semi-Annual Micro-Cap Conference in New York City on January 13, 2014 January 08, 2014 08:00 AM Eastern Standard Time Sidoti & Company Semi-Annual Microcap Conference ASHKELON, Israel–(BUSINESS WIRE)–Integrity Applications, Inc. (OTCQB:IGAP), developer of the GlucoTrack® model DF-F non-invasive blood glucose measurement device, today announced that Avner […]

Read More

Integrity Applications Spotlights GlucoTrack®Model DF-F Glucose Monitoring Device on World Diabetes Day 2013

November 14th, 2013

http://www.businesswire.com/news/home/20131113006801/en Integrity Applications Spotlights GlucoTrack®Model DF-F Glucose Monitoring Device on World Diabetes Day 2013 Device Offers Global Diabetes Community the Ability To Obtain Blood Glucose Measurements Non-Invasively November 14, 2013 01:00 AM Eastern Standard Time ASHKELON, Israel–(BUSINESS WIRE)–Integrity Applications, Inc. (OTCQB:IGAP), developer of the GlucoTrack®model DF-F non-invasive blood glucose measurement device, acknowledged World Diabetes Day […]

Read More

Integrity Applications to Present at the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference

October 29th, 2013

Integrity Applications to Present at the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference Press Release: Integrity Applications, Inc. – 10 hours ago RELATED QUOTES Symbol Price Change IGAP 8.50 0.00   ASHKELON, Israel–(BUSINESS WIRE)– Integrity Applications, Inc. (IGAP), developer of the GlucoTrack®model DF-F non-invasive blood glucose measurement device, announced that  Avner Gal, the Company’s […]

Read More

Integrity Applications to Present and Exhibit at the 2013 Meeting of the European Association for the Study of Diabetes in Barcelona

September 24th, 2013

Integrity Applications to Present and Exhibit at the 2013 Meeting of the European Association for the Study of Diabetes in Barcelona CEO Avner Gal Will Present Poster on GlucoTrack® DF-F Monitoring Device ASHKELON, Israel – September 24, 2013 — Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack® model DF-F non-invasive blood glucose measurement device, […]

Read More Download

Integrity Applications, Inc. (OTC/QB: IGAP) announced today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood glucose measurement device.

June 4th, 2013

INTEGRITY APPLICATIONS RECEIVES CE MARK APPROVAL FOR ITS GLUCOTRACK® MODEL DF-F GLUCOSE MONITORING DEVICE ASHKELON, Israel (June 4, 2013) – Integrity Applications, Inc. (OTC/QB: IGAP) announced  today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood  glucose measurement device. Receipt of the CE Mark allows Integrity Applications to market  and sell […]

Read More Download

INTEGRITY APPLICATIONS COMMON STOCK IS PUBLICLY QUOTED ON THE OTC BULLETIN BOARD UNDER THE SYMBOL “IGAP”

April 10th, 2013

INTEGRITY APPLICATIONS COMMON STOCK IS PUBLICLY QUOTED ON THE OTC BULLETIN BOARD UNDER THE SYMBOL “IGAP”   Raises approximately $6.3 million to advance the development and commercialization of GlucoTrack® for the non-invasive measurement of blood glucose   ASHKELON, Israel (April 9, 2013) – Integrity Applications, Inc. (OTCQB:IGAP), developer of the GlucoTrack DF-F non-invasive blood glucose […]

Read More Download

Frost & Sullivan Recognizes Integrity Applications for Path-Breaking Technology Innovation…

July 16th, 2008

Frost & Sullivan Recognizes Integrity Applications for Path-Breaking Technology Innovation and Growth Potential in the Non-Invasive Glucose Monitoring Markets PALO ALTO, Calif.–(Business Wire)– Based on its recent analysis of the biosensors market, Frost & Sullivan recognizes Integrity Applications Ltd. with the 2008 North American Frost & Sullivan Product Innovation Leadership of the Year Award for developing the […]

Read More

Sign up to our newsletter
To receive occasional news updates

LinkedIn Facebook Twitter